Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
暂无分享,去创建一个
T. Pieber | C. Mathieu | B. Bode | J. Gumprecht | M. V. von Herrath | T. Hansen | S. Bain | K. Coppieters | J. Clausen | Leylya Gaysina | C. Morales | Ofri Mosenzon | S. Segel | G. Tsoukas | L. Gaysina